Three months into a Wegovy weight-loss journey is often when people start to measure themselves against their expectations, whether those expectations came from online accounts, clinical trial headlines, or something someone told them at the pharmacy. The reality, as with most things in medicine, is more individual than the averages suggest. This guide sets out what the clinical evidence says, why results vary, and what to look for beyond the numbers on the scales.
How Does Wegovy Work and Why Does Timing Matter?
Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist that works by suppressing appetite in the brain, slowing gastric emptying, and improving insulin sensitivity. Because Wegovy injections for weight loss follow a gradual dose escalation, starting at 2.5 mg and increasing every four weeks, the first three months of treatment span the introductory and lower therapeutic doses. By week twelve, most patients are reaching the 7.5 mg or 10 mg dose range, having moved through 2.5 mg, 5 mg, and into the middle of the schedule.
This matters because the most significant Wegovy weight loss results build progressively. The early weeks are characterised by appetite suppression beginning to take effect, side effects being most prominent, and the body adjusting to the medication. The bigger results tend to come later.
Wegovy Results After 3 Months: What the Evidence Shows
The STEP 1 clinical trial, the pivotal study that led to Wegovy’s MHRA approval in the UK, ran for 68 weeks and showed an average weight loss of approximately 14.9% of body weight. However, looking at the 12-week mark from published data gives a more specific picture of what to expect at the three-month point.
At approximately 12 weeks (three months), participants in the STEP trials had typically lost between 5% and 8% of their starting body weight on average. For someone starting at 100 kg, that translates to roughly five to eight kilograms. For someone starting at 120 kg, the absolute figure is higher, but the percentage is similar.
These are averages. Some people will be above this range at three months, and some will be below. Neither position tells you everything about where you will end up by six or twelve months.
The Wegovy Results Timeline: Month by Month
| Period | Dose | Typical Experience |
| Month 1 | 2.5–5 mg | Appetite begins to reduce. Side effects (nausea, fatigue) most prominent. Weight loss modest: typically 1–3 kg. Do not judge overall success at this stage. |
| Month 2 | 5–7.5 mg | Appetite suppression becomes more consistent. Side effects begin to ease for many. Weight loss accelerates: typically 2–4 kg in this month alone. |
| Month 3 | 7.5–10 mg | Cumulative loss of 5–8% body weight on average by end of month 3. Many notice clothing fit changing. Progress feels more stable. |
| Month 4–6 | 10–15 mg | Most significant weight loss phase for many. Cumulative results building toward the 10–15% range. Side effects usually settled. |
| Month 7+ | 15 mg (max) | Maintenance and continued loss toward trial averages of ~15%. Individual variation widens. Plateaus are normal. |
Note: This timeline is based on published STEP trial data and represents averages. Individual results vary. All weight loss figures are cited as averages from clinical trials and are not guaranteed outcomes.
Why Do Wegovy Results Vary Between People?
The range of Wegovy weight loss results at three months and beyond reflects several factors that differ between individuals:
- Starting weight and BMI: those with a higher starting weight typically lose more in absolute terms in the early months, though the percentage loss is often similar
- Dose reached by three months: not everyone escalates at the same pace if side effects require slowing the titration
- Dietary habits during treatment: appetite suppression reduces intake, but the quality and composition of what is eaten still matters
- Presence of type 2 diabetes or insulin resistance: semaglutide’s effects on blood sugar can influence how the body responds to the calorie deficit
- Individual biological variation: GLP-1 receptor sensitivity varies between people, meaning the same dose can produce different degrees of appetite suppression
This is why comparisons with others are rarely productive. Your own Wegovy weight loss journey is best assessed against your own baseline, not against someone else’s account.
What Else to Look for Beyond the Scales
How much weight can you lose with Wegovy is the question most people ask, but it is not the only meaningful measure of how well the medication is working. At three months, other indicators worth noting include:
- Reduction in waist circumference, which often reflects metabolic improvement even when scale weight has plateaued
- Improved energy levels and reduced food preoccupation as appetite suppression stabilises
- Better blood sugar readings or improved HbA1c, particularly in those with diabetes or pre-diabetes
- Changes in clothing fit, which can precede noticeable scale changes when body composition is shifting
- Reduced interest in high-calorie, processed foods, which tends to become more pronounced as treatment progresses
What If Your Results Feel Slower Than Expected?
If your Wegovy weight loss results at three months feel slower than the averages suggest, there are a few things worth considering before concluding. Firstly, the scale does not always reflect what is happening in the body. Fluid retention, particularly in the early weeks, can mask fat loss. Secondly, dose escalation may have been slower than the standard schedule, which is appropriate if side effects required it, but does mean that full appetite suppression arrives later.
If you have reached the 10 mg or higher dose and are seeing minimal weight loss, this is worth discussing with your prescriber. Non-response to semaglutide does occur in a small percentage of patients, and exploring whether the treatment is working as expected is a legitimate part of clinical review.
How to Get Started with Wegovy Injections for Weight Loss
Wegovy is a prescription-only medicine. The right starting point is a professional assessment to confirm eligibility, set realistic expectations, and establish clinical oversight from the outset.
At Touchwood Pharmacy, our pharmacists can guide you through every stage of the Wegovy weight loss journey, from first dose to ongoing support, and help you interpret your progress in context.
Book your appointment with our experts at Touchwood Pharmacy for personalised weight management advice and access to safe, clinically guided Wegovy treatment.
This article is for informational purposes only and does not constitute medical advice. Wegovy is a prescription-only medicine. Weight loss figures cited are averages from clinical trials and are not guaranteed outcomes. Always consult a qualified healthcare professional before starting, stopping, or adjusting any medication.
Frequently Asked Questions (FAQ’s)
How much weight can I expect to lose with Wegovy in 3 months?
Clinical trial data from the STEP programme suggests that patients lose an average of 5% to 8% of their starting body weight over the first three months. For someone weighing 100 kg at the start, that is roughly five to eight kilograms. Results vary between individuals depending on starting weight, dose reached, dietary habits, and individual response to the medication.
Is 3 months long enough to see Wegovy results?
Three months is enough to see meaningful progress, but it is not the peak of the Wegovy results timeline. The most significant weight loss typically occurs between months three and nine, as the dose escalates toward the maintenance level and cumulative results compound. Judging Wegovy’s effectiveness at three months captures only part of the picture.
Why am I not losing weight on Wegovy after 3 months?
If weight loss has been minimal after three months, a few factors are worth considering. Dose escalation may still be ongoing, meaning full appetite suppression has not yet been reached. Fluid retention in the early weeks can obscure fat loss on the scales. Dietary habits may be counteracting the calorie reduction the medication aims to create. If you are at the 10 mg or higher dose and not seeing results, discuss this with your prescriber, as non-response to semaglutide does occur and may warrant a review of the treatment plan.
Does Wegovy work faster if you exercise?
Exercise is additive to Wegovy weight loss results rather than a prerequisite. The medication’s appetite-suppressing mechanism functions independently of physical activity. Exercise helps preserve lean muscle mass during weight loss, supports metabolic health, and can improve long-term weight maintenance, but it is not required for semaglutide to work. See our companion article on Wegovy and exercise for more detail.
What happens after 3 months on Wegovy?
After three months, most patients are approaching or reaching the middle of the dose escalation schedule. The months that follow, particularly months four through nine, tend to produce the most consistent and visible weight loss as the dose approaches the 15 mg maintenance level. The Wegovy weight loss journey is designed to be a long-term programme, not a short-term fix.
Is Wegovy safe to use for longer than 3 months?
Yes. Wegovy is licensed in the UK for long-term weight management. The STEP clinical trials ran for 68 weeks, and the safety and efficacy data support extended use under appropriate clinical supervision. Any decision about continuing, adjusting, or stopping treatment should be made in partnership with your prescriber rather than based on results at any single time point.
